Genomics & Biotech Innovation ETFs
IDNA — iShares Genomics Immunology and Healthcare ETF
iShares · NYSE FactSet Global Genomics · since 2019
Index-based genomics with a cap on single-name weight, so far less concentrated than ARKG.
- Expense ratio
- 0.47%
- AUM
- $200M
- Dividend yield
- 0.2%
- 1Y return
- +14.6%
- 3Y ann.
- +2.4%
- 5Y ann.
- -6.9%
- 10Y ann.
- —
- All-time ann.
- —
Top holdings
- Vertex Pharmaceuticals4.90%
- Regeneron4.40%
- Illumina4.10%
- Alnylam3.90%
- Moderna3.10%
50 total holdings · 34.0% in the top 10